← Browse by Condition
Medical Condition

udt1

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1, Phase 2
NCT05535413 Phase 1, Phase 2
Recruiting

UTD1 Combined With Capecitabine in Metastatic HER2-negative Breast Cancer Patients With Brain Metastases

Enrollment
30 pts
Location
China
Sponsor
Hunan Cancer Hospital
View Trial →